c

There is absolutely nothing of any good news of clown Les G performing in the big booze show from his pig stale apartment. Why is Les agreeing to perform in a bar surrounded by alcohol and quack like an idiot duck making a complete fool of himself? Its because he wants to sell his securities and for no other reason. If any material news would come any time soon Les would not perform in this idiot scenery, because that would mean that there would be no need to sell NWBO securities at this low-level SP.

Let hope so

and its only the last one that counts smartypants. As a short, you dont get to choose which trial protocol counts

https://www.statnews.com/2023/06/06/novocure-optune-electric-fields-device-lung-cancer/
your buddy Adam disagrees with you lol

if it wasnt clear you are a Novocure inside men its clear now. What I do puzzle with is why dont you come forward and just say that you are.

Good quote
Mark Twain realized that some need to be informed of the immense lies that a few are trying to mislead others with. So therefore I exchange with some fools to correct them and put the truth out. Mark Twain would have appreciated those that protect others who are easily misled by lies. That's the kinda guy Mark was.

Then let me quote Mark Twain for you
“It's easier to fool people than to convince them that they have been fooled.”

sorry to hear you can't handle FACTs from FICTION. Are those 1.2 billion naked shorts here with you now in the room?

This is what is happening to many biotechs over the last few years its a common trap, and NWBO was not the only one. As a matter of fact, I wrote about this phenomenon 14 months ago and was of course shut down here.

Longs load up on anticipation of TLD, then an attack on the SP after positive TLD, Longs then panic and start selling to pocket their gains from the last weeks in anticipation of TLD. Short sellers who started the panic cover their short position. I read an extensive article about it in Yahoo Finance two years ago. It works really well because many longs think they can have a nice gain after TLD and there are no longs who want to buy after the fact of TLD.

Im fairly confident they are in a rolling review, at least that is what I have heard. Therefore the moment they added, changed the last info or scanned the last page or whatever they are doing to the million/million and a half pages of the MAA application they can submit it which at the same time is then accepted by the MHRA since its a rolling review.

So application submittal of the application IS the same as acceptance by the MHRA.

Thanks to Senti who duck up the old PR

1. DCVAXL has in ancient history treated patients with DCVAXL for other indications than GBM
https://www.biospace.com/article/releases/northwest-biotherapeutics-conducting-ovarian-cancer-clinical-trial-with-dcvax-r-l-at-university-of-pennsylvania-first-patients-enrolled-and-being-tre/

dropdown menu from 23 Jul 2011 - 30 Dec 2019
and with that undeniable fact provided by way back machine, this myth has been busted.

Dude,

NWBO many years ago already treated different patients in a DCVAXL Phase 1 and 2 for different cancer indications. That's what Dr Bosch here is referring to. NWBO does NOT have the right to sell DCVAXL outside GBM for other cancer indications.

Know your NWBO history.

dude thats from the P2 trial from literally 10 years ago

Thermo's brother has been treated for prostate many years ago

https://nwbio.com/dcvax-prostate/

Now I literally have to quote Page 4 to dismiss this ongoing BS. I have better things todo

I provided you with a reliable source that disputes your claim and this is your best response?

No source no quoting of a RA regulation Just your "trust me I know better". Well, news for you no one relies on the "trust me bro" source. Provide a reliable source where it can derived from NWBO has been granted the right to sell DCVAXL for other cancers for compassionate use than GBM. I'm waiting.

I replied incorrectly my apologies. What I am saying is that just because they added this form https://nwbio.com/patient-inquiry/ without any PR doesn't mean that somehow they now have permission to, without any new trial, offer compassionate use for all solid tumors. They just dont have that permission

https://www.ema.europa.eu/en/human-regulatory/research-development/compassionate-use

But then it disappeared again from the NWBO website. Look it would be awesome but when it comes to NWBO I am on a first believe then see basis

No the evil shorts are somehow withholding Linda to file a request for approval. No idea how but Damm you shorts grrr

Holy moly. Did the fulltime NWBO CTO attempt to change something about MWBOs website??

That is huge. It failed but still huge, ;)

there is no long that appreciates dilution, fall of stock price, and slow as mud deliveries.
And if a long appreciates dilution, low SP, and slow delivery by management he/she should check in with a self-mutilation clinic

To be fair the market in general for non revenue biotechs for years now has shifted from awarding the binary topline data event to show me the money events such as approvals or licensing or rumors of buy out. That’s not just NWBO.

Please provide an alternative pharmaceutical compound or biologic that shares the identical mechanism of action as Trodelvy (Immunomedics ) in triple-negative breast cancer and exhibits a similar therapeutic response. Can you?

And while you add it, please provide a quote in any of my posts where I claimed DCVAXL is not effective and unique in the treatment of GBM, which I never claimed. Can you?

all nonrevenue cancer drug biotechs and their shareholders claim their platform is the best of the best unique and groundbreaking, one-of-a-kind, never seen before bla bla bla. Immunomedics claimed they were incredible and unique and their shareholders said it

NWBO shareholders saying it is no different.

I will say it too if that will x10 the SP :)